ADNTRO Genetics — Seed (estimated) · €1M

Bio & Tech Smart Capital FCRE, the venture fund of Noso Capital, invested €1M in Palma-based ADNTRO Genetics to scale N-GENE, a genetic testing platform for healthcare professionals in preventive and personalised medicine. Founded in 2019, ADNTRO serves over 50,000 consumers across 70 countries alongside its professional product.